№ files_lp_4_process_3_112936
File format: docx Character count: 993 File size: 1366 KB
Medical record documenting the administration of thickening agents to residents with specified IDDSI steps and exact dosage for each serving.
Year: 2015
Institution: NHS
Document Type: Medical administration record
Subject: Fluid and food thickener usage
Resident Name: [To be filled]
Date of Birth: [To be filled]
Product: [To be filled]
Date Opened: [To be filled]
Use By Date: [To be filled]
IDDSI Step: Step 1, Step 2, Step 3, Step 4
Number of Scoops per 200ml: [To be filled]
Completed By: [To be filled]
Checked By: [To be filled]
Reference: PSA Alert NHS/PSA/W/2015/002
URL: https://www.england.nhs.uk/wp-content/uploads/2019/12/psa-thickening-agents.pdf
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Information for GPs regarding IDDSI
Year: 2018
Region / city: Luton and Dunstable
Topic: Dysphagia, Food and Fluid Texture Modification
Document Type: Patient Safety Alert
Organization: NHS Improvement
Author: Speech and Language Therapy Team
Target Audience: General Practitioners, Healthcare Providers
Period of Action: Starting April 1, 2019
Approval Date: June 2018
Date of Changes: April 1, 2019
Gliclazide: Uses, Dosage, Side Effects and Driving Guidance
Medicine name: Gliclazide
Therapeutic class: Oral hypoglycaemic agent
Indications: Type 2 diabetes; monogenic diabetes; steroid-induced diabetes
Form: Tablet
Administration: Once or twice daily with food
Dose adjustment: According to blood glucose levels under medical supervision
Common adverse effects: Nausea; diarrhoea; constipation; weight gain
Serious adverse effects: Hypoglycaemia; liver dysfunction; blood cell disorders
Contraindications: Type 1 diabetes; severe kidney disease; severe liver disease; pregnancy; breastfeeding; concomitant miconazole use; porphyria
Driving regulations: Notification required to DVLA for Group 2 licence holders
Monitoring requirements: Regular blood glucose monitoring; mandatory monitoring for Group 2 drivers during driving
Issuing institution: Edinburgh Centre for Endocrinology and Diabetes
Document type: Patient information leaflet
Geographical reference: United Kingdom
Natural variation and dosage of the HEI10 meiotic E3 ligase control Arabidopsis crossover recombination
Year: 2016
Region / city: Not specified
Topic: Genetics, Plant Biology
Document Type: Research Article
Institution: Not specified
Author: Piotr A. Ziolkowski, Charles J. Underwood, Christophe Lambing, Marina Martinez-Garcia, Emma J. Lawrence, Liliana Ziolkowska, Catherine Griffin, Kyuha Choi, F. Chris H. Franklin, Robert A. Martienssen, Ian R. Henderson
Target Audience: Researchers, Academics
Period of Action: Not specified
Approval Date: Not specified
Modification Date: Not specified
Purchase of Laboratory equipment Spectrophotometer for research project titled "Effect of different dosage of enrofloxacin on clinical efficacy and resistance development against fowl typhoid" under the HEC Funded Project "Genetic and molecular appraisal of selected chickpea (Cicer arietinum L.) Genotypes"
Year: 2020
Region / city: Peshawar
Subject: Laboratory equipment purchase
Document type: Tender
Organization: The University of Agriculture, Peshawar
Author: Not specified
Target audience: Registered firms, suppliers, authorized distributors
Period of validity: 90 days from bid opening
Approval date: 03-01-2020
Date of changes: 20-01-2020
Tender submission deadline: 20-01-2020, 01:45 p.m.
Tender opening date: 20-01-2020, 02:00 p.m.
Tender fee: Rs. 500
Earnest money: 2% of tender cost
Warranty period: 1 year
Bid validity period: 90 days
Bid bond requirement: 3% of quoted price
Note: Document type Tender notice
Description: A tender notice for the purchase of laboratory equipment (Spectrophotometer) for a research project at The University of Agriculture, Peshawar, including conditions for submission and specifications.
Order and Dosage Calculation for Pharmaceutical Practices
Year: 2008
Region / City: United States
Topic: Pharmaceutical practice, medication dosage, pharmacy regulations
Document Type: Educational material
Author: Not specified
Target Audience: Pharmacists, pharmacy technicians, medical professionals
Period of Validity: Not specified
Approval Date: Not specified
Modification Date: Not specified
Working out a dosage from a label - Digoxin
Note: Year
Topic: Dosage calculation
Document type: Educational material
Target audience: Healthcare professionals
Medical Dosage Calculations and Conversions for Patients
Year: 2026
Region / City: Not specified
Subject: Pharmacology, Dosage Calculation
Document Type: Educational / Reference Material
Institution / Organization: Not specified
Author: Not specified
Target Audience: Healthcare professionals, nursing students
Measurement Units: grams, milligrams, micrograms, milliliters, units
Dosage Forms: Tablets, capsules, syrup, injections
Calculation Methods: Conversion, ratio, rate, drip calculation
Contextual Period: Present clinical practice
Prescription Examples Included: Yes
Topics: Thickener IDDSI Dosage